Investment analysts at StockNews.com started coverage on shares of Brooklyn ImmunoTherapeutics (NYSE:BTX – Get Rating) in a report issued on Sunday. The firm set a “hold” rating on the stock. Brooklyn ImmunoTherapeutics Stock Performance NYSE BTX opened at $3.48 on Friday. Brooklyn ImmunoTherapeutics has a 1 year low of $0.17 and a 1 year high […]